SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001773427-22-000019
Filing Date
2022-05-05
Accepted
2022-05-05 06:38:35
Documents
14
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K swtx-20220505.htm   iXBRL 8-K 37513
2 EX-99.1 swtx-20210331xearningsrele.htm EX-99.1 51933
6 GRAPHIC springworkslogoq12022.jpg GRAPHIC 7112
  Complete submission text file 0001773427-22-000019.txt   245671

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT swtx-20220505.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT swtx-20220505_lab.xml EX-101.LAB 23896
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT swtx-20220505_pre.xml EX-101.PRE 12602
8 EXTRACTED XBRL INSTANCE DOCUMENT swtx-20220505_htm.xml XML 11866
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 22893899
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences